On Monday, the UCI announced that Jarlinson Pantano of WorldTour team Trek-Segrafedo failed an out-of-competition doping control during the winter. The 30-year-old Colombia who’s career highlights include stage wins at the 2016 Tour de France and Tour de Suisse, was notified for an adverse analytical finding for the blood booster Erythropoietin.
The sample was collected on Feb. 26, after Pantano had raced the Santos Tour Down Under, Cadel Evans Ocean Road Race, Herald Sun Tour and Tour du Haut Var. Two weeks later, Pantano started Paris-Nice where his to stage finish was 36th on Stage 4.
Pantano has been provisionally suspended by the UCI but has the right to request the B sample be analyzed.
Following the announcement, Trek-Segrafedo released a statement: “It is with deep disappointment that we have just learned that our rider, Jarlinson Patano, has been notified of an adverse analytical finding in a sample collected during an out of competition control carried out by the Cycling Antidoping Foundation. In accordance with our zero-tolerance policy, he has been suspended immediately.
“We hold our riders and staff to the highest ethical standards and will act and communicate accordingly as more details become available.”
Pantano was scheduled to start the Giro d’Italia.